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applications including bioimaging,[1–4] 
biolabeling,[5] sensing,[3,4,6,7] and therapy.[8] 
They are composed of several up to tens 
of gold atoms, giving rise to ultrasmall 
sized structures of less than 2 nm.[9] Due 
to their small size, they demonstrate 
molecule-like properties having discrete 
valence electronic states approaching 
the molecular orbitals.[10,11] They do not 
exhibit plasmon resonance as in case 
of larger gold nanoparticles but rather 
show fluorescence in the visible or the 
near-infrared (NIR) region.[12] Among 
their unique properties, having long life-
time NIR fluorescence, high two-photon 
excitation, and photostability alongside 
with biocompatibility[13] allow them to 
be attractive for imaging in tissue and in 
vivo.[2]
In addition to the quantum confine-
ment effect, ligands play a fundamental 
role in controlling the chemical and phys-
ical properties of AuNCs.[14] Generally, 
nanoclusters form out of metal core–shell 
structure stabilized by ligands as staple-
like motifs on the surface.[10] Tuning 
emission wavelength and intensity can 
be acquired by controlling the core size during synthesis.[15] 
In another scenario, charge transfer or electron donation from 
the ligands active groups to the metal core contributes as well 
in regulating the fluorescence properties.[16,17] Ligands can 
Gold nanocluster (AuNC) synthesis using a well-distinguished polymer for 
nanoparticle-mediated drug delivery paves the way for developing efficient 
theranostics based on pharmaceutically accepted materials. Gelatin-stabilized 
AuNCs are synthesized and modified by glutathione for tuning the emission 
spectra. Addition of silver ions enhances the fluorescence, reaching also high 
quantum yield (26.7%). A simplified model can be proposed describing the 
nanoclusters’ properties–structure relationship based on X-ray photoelectron 
spectroscopy data and synthesis sequence. Furthermore, these modifications 
improve fluorescence stability toward pH changes and enzymatic degradation, 
offering different AuNCs for various applications. The impact of nanocluster 
formation on gelatin structure integrity is investigated by Fourier transform 
infrared spectrometry and matrix-assisted laser desorption/ionization time of  
flight mass spectroscopy, being important to further formulate gelatin nano-
particles (GNPs). The 218 nm-sized NPs show no cytotoxicity up to 600 µg mL−1 
and are imaged in skin, as a challenging autofluorescent tissue, by confocal 
microscopy, when transcutaneously delivered using dissolving microneedles. 
Linear unmixing allows simultaneous imaging of AuNCs–GNPs and skin with 
accurate signal separation. This underlines the great potential for bioimaging of 
this system to better understand nanomaterials’ behavior in tissue. Additionally, it 
is drug delivery system also potentially serving as a theranostic system.
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1. Introduction
Gold nanoclusters (AuNCs) have gained growing interest 
recently, due to their unique properties and various potential 
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stabilize the fluorescence of AuNCs against environmental con-
ditions such as change of pH and temperature, etc.[18]
Proteins and peptides are attractive stabilizing, capping, 
and templating agents for AuNC synthesis. They offer mild 
reaction environment, water solubility, and biocompat-
ibility which are all preferred attributes for the fabrication 
of metal nanoclusters.[19] Additionally, proteins possess bio-
logical, medicinal, and pharmaceutical applications. Glu-
tathione has been extensively used for AuNC synthesis[4,20–24] 
due to the strong affinity of the thiol group to form AuS 
bond.[23,25] Cysteine-containing proteins such as bovine serum 
albumin,[26–31] insulin,[32,33] trypsin,[34,35] and lysozyme[36,37] 
have been also explored for the same purpose. Other studies 
have also shown that basic amino acids together with tyrosine 
and tryptophan can contribute to the reduction of the ions to 
metallic gold.[38] Additionally, it has been reported that the pro-
tein organizational structure is controlling the NCs’ properties, 
where amyloid fibril (cross-β-sheet structures) formation can 
lead to redshift in fluorescence.[39]
However, the mechanism of nanocluster formation is still 
not fully understood. Careful selection of the suitable ligand 
for optimizing and stabilizing the optical properties of the 
nanoclusters is a prerequisite. On the other hand, correlating 
the physicochemical properties of AuNCs to their structure 
is very crucial. It is a step toward better understanding and 
easier properties manipulation to fulfill different applications. 
X-ray photoelectron spectroscopy (XPS) can act as a useful tool 
to investigate the effect of ligands on the atomic structure of 
AuNCs by studying the oxidation state of the clusters forming 
elements and the binding properties.[10,27]
Synthesis of AuNC-labeled pharmaceutical proteins and 
polymers will pave the way and allow to obtain multifunc-
tional nanoparticles (NPs) for simultaneous drug delivery and 
bioimaging and/or biosensing. Gelatin represents a promising 
carrier that has been widely used for the delivery of biomacro-
molecules and hydrophilic drugs[40] due to its hydrophilicity, 
biodegradability, and biocompatibility. The biocompatibility of 
the multifunctional NPs is essential; where AuNCs are easily 
excreted from the body due to their small size, less than the 
renal clearance cutoff, and gelatin NPs will degrade and solu-
bilize. Up to our knowledge, gelatin has not been investigated 
yet for synthesis of fluorescent AuNCs, despite its widespread 
use in preparation of gold nanoparticles. We envisage that 
the gelatin-mediated synthesis of AuNCs might open the 
door for various pharmaceutical or biomedical applications. 
In this regard, we have succeeded to synthesis NIR-emitting 
AuNCs using gelatin. By varying the reaction conditions, we 
have managed to control the fluorescence properties of the 
resulting nanoclusters. AuNC-modified gelatin has proved 
to be capable of forming nanocarriers (gelatin nanoparticles 
(GNPs)) with the ultimate goal of imaging in tissue. Such 
system can be of high potential for theranostics for simulta-
neous bioimaging and delivery of macromolecules such as 
antigens.
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Figure 1. Gold nanoclusters stabilized by gelatin only; a) Effect of gold molar concentration and b) effect of pH on the maximum fluorescence emmi-
sion at 640 nm. Gold nanoclusters stabilized by gelatin and glutathione (GSH); c) Effect of GSH concentration on the fluorescence of AuNCs at 
690 nm, when used alone (Au–GSH) and in combination with gelatin (AugB–GSH) and d) effect of pH on the maximum fluorescence emission of the 
gelatin–GSH-stabilized AuNCs at 690 nm AugB–GSH: describes nanoclusters stabilized using gelatin B and different concentrations of glutathione. 
Au–GSH: is the nano cluster stabilized with different concentrations of glutathione only without using gelatin.
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2. Results and Discussion
2.1. Synthesis of Gelatin-Stabilized AuNCs
Gelatin is a natural polymer consisting of a mixture of proteins 
and polypeptides that result from the hydrolysis of collagen. We 
have utilized gelatin type B to sequester and reduce Au (III) to 
Au (0) that combine together to form AuNCs emitting fluores-
cence at λmax 640 nm. For optimizing the synthesis process, dif-
ferent gold concentrations and pH values have been tested. The 
fluorescence intensity directly rises with Au concentration up to 
5 × 10−3 m, while further increase in concentration resulted in 
a gradual loss of fluorescence (Figure 1a and Figure S1 (Sup-
porting Information)). The latter effect is due to the formation 
of larger gold nanoparticles that influence the fluorescence 
negatively by quenching.[41] At a concentration of 30 × 10−3 m 
gold chloride, only gold nanoparticles have been produced as 
observed by transmission electron microscopy (TEM) (Figure S2a, 
Supporting Information). On the other hand, adjusting 
the pH was crucial to initiate the reaction between gold and 
gelatin. At pH range (7–12), the fluorescence increased with pH 
to be maximized at pH 12 (Figure 1b). Among the amino acids 
composition of gelatin, the basic amino acids; arginine (8%)[42] 
and lysine (4%)[42] can reduce Au (III) ions to Au (0) by electron 
transfer from the side chain amines. According to Xu et al., argi-
nine and lysine can form complexes with Au3+ that can be fur-
ther reduced by tyrosine under alkaline conditions,[38] however 
tyrosine represents only <0.5% of gelatin weight.[42] On the other 
hand, glutamic acid (10%)[42] can contribute to the thermal reduc-
tion of gold ions.[43] All these mechanisms can be contributing 
variably to the formation of AuNCs.
The polymer backbone structure and viscosity play a role in 
controlling the growth rate and the stabilization of AuNCs. In 
this regard, gelatin B showed better efficiency to form fluorescent 
AuNCs compared to gelatin A (Figure S3a, Supporting Informa-
tion). This can be attributed to the glutamic acid content of gelatin 
B which results from the alkaline hydrolysis 
of collagen.[44] Additionally, more free amines 
are expected in gelatin B due to the lower iso-
electric point (4–6) compared to 7–9 in gelatin 
A.[45] On the other hand, gelatin B of higher 
bloom (225 g) resulted in less fluorescence 
compared to bloom 75 g (Figure S3b, Sup-
porting Information), which might be due to 
the higher flexibility of short polymer chains to 
interact with gold ions. Although the viscosity 
contributes to the AuNC stability, the exces-
sively increased viscosity can possibly reduce 
the electron transfer to Au ions, resulting 
in lower reduction rate.[46] For upscaling the 
AuNC production, multiples of gelatin concen-
trations have been tested while multiplying the 
Au concentration to keep the ratio unchanged 
(Figure S4, Supporting Information).
Glutathione (GSH) is a strong reducing 
agent that has been widely used for the prepa-
ration of AuNCs due to the presence of thiol 
group (SH). One-pot synthesis of AuNCs 
using gelatin and different concentrations of 
glutathione allowed tuning the emission spectrum of the nano-
clusters (Figure S5, Supporting Information). Selected GSH con-
centration of 10 × 10−3 m resulted in 50 nm redshift in the AuNC 
fluorescence (λem = 690 nm). Interestingly, GSH alone, with the 
same concentration and under the tested reaction conditions, 
resulted in negligible fluorescence. Only GSH of concentration of 
15 × 10−3 m resulted in detectable fluorescence when reacted with 
gold chloride that has been even enhanced by gelatin addition 
(Figure 1c). This proves the synergistic contribution of gelatin and 
GSH to form AuNCs. Ligand modification and so the introduction 
of more electron-rich functional groups can manipulate the elec-
tron transfer to the metal core, and thus influence the fluorescent 
properties of AuNCs.[16] Additionally, increasing the pH from 7 to 
12 resulted in gradual increase in the fluorescence (Figure 1d).
2.2. Structure Integrity of Gelatin during AuNC Formation
A compromise between the AuNC formation and maintaining 
gelatin’s integrity is necessary to further use the polymer for 
pharmaceutical purposes. Controlling the pH has the compe-
tence to manipulate the reaction rate (Figure 2a). Simultaneously, 
it affects the gelatin structure, especially at high temperature. At 
pH 12, after 6 h of the reaction with gold ions, gelatin has lost 
its gelling properties when cooled to 4 °C. By contrast, pH 11 
preserves the gelation properties of the polymer till completion 
of the reaction at 24 h (Figure S6, Supporting Information). For 
further investigations about the gelatin structure, ninhydrin test 
has been performed to quantify the free amine groups over dif-
ferent time intervals of the interaction with gold. After 1 h of 
reaction at pH 12, the free amino groups have been reduced to 
87% and this can be attributed to the coordination established 
between NH2 and Au. Then, the % increased to 94 after 3 h, 
continuing gradually to reach 145% after 24 h of the reaction, 
indicating gelatin degradation and hence the increase of free 
amine groups of the polypeptide (Figure 2b).
Adv. Healthcare Mater. 2019, 1900993
Figure 2. a) Effect of GSH addition and change of pH on the reaction rate for the formation of 
gelatin-stabilized AuNCs; represented by fluorescence intensity. The different tested reaction 
conditions are; 4% w/v gelatin at pH 12 (AugB/pH 12), 4% w/v gelatin and 10 × 10−3 m GSH at 
pH 12 (AugB–GSH/pH 12), and 4% w/v gelatin and 10 × 10−3 m GSH at pH 11 (AugB–GSH/pH 
11). b) Quantification of the free amine groups of gelatin after different reaction times with gold 
chloride at pH 12 (AugB/pH 12) using ninhydrin test. AugB represents nanoclusters stabilized 
by gelatin B at different pH and reaction times.
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Two AuNC formulations have been selected, so far, for fur-
ther studies: AuNCs synthesized by gelatin at pH 12 and 3 h 
of reaction (Aug) and the other prepared by gelatin and GSH 
at pH 11 after 24 h reaction (AuS) (Table S1, Supporting 
Information). These formulations showed well detectable fluo-
rescence by confocal microscopy upon excitation at 405 nm 
(Figure S7b, Supporting Information). They have been exam-
ined as well by Fourier transform infrared spectrometry (FT-IR) 
and matrix-assisted laser desorption/ionization time of flight 
mass spectroscopy (MALDI-TOF MS) to reveal the changes 
in gelatin structure in comparison to the untreated polymer. 
MALDI-TOF MS is a common tool to study the core size of 
AuNCs and ligand composition. However, calculating the AuNC 
core size by detecting the number of gold atoms in such a case 
was not an accessible option due to the heterogeneous mass 
of the gelatin polypeptides mixture, in addition to the possible 
fragmentation of the nanoclusters during ionization.[27,47] In 
parallel, the examination of the change in the mass spectrum of 
gelatin could be determined. Figure 3a shows the mass spectra 
of gelatin and both nanocluster formulations: Aug and AuS. 
Peaks of lower molecular weight (m/z ≈ 3100) appear in both 
Aug and AuS. The two spectra show other regions of almost 
similar m/z ratio compared to untreated gelatin, with variable 
peak intensities. Using the specified conditions for Aug and 
AuS synthesis controlled gelatin degradation while maintaining 
the gelling properties as has been observed earlier (Figure S6, 
Supporting Information).
On the other hand, FT-IR is used commonly to investigate 
the conformational changes of proteins and peptides, especially 
in the secondary structure. Amide I (1600–1700 cm−1, mainly 
due to CO stretching vibration) and amide II (≈1550 cm−1, NH 
bending and CN stretching vibrations) are characteristic bands 
for the secondary structure. However, correlating the secondary 
structure to amide II is less straightforward than amide I.[48]  
Untreated gelatin showed amide I band at 1629 cm−1 
(Figure 3b), revealing β-sheets’ secondary structure (indicated 
by amide I in the range 1623–1641 cm−1).[48] A very small shift 
to 1632 cm−1 after the reaction with gold (in Aug and AuS) indi-
cates no or minimal changes in the secondary structure. By 
controlling the pH along with the reaction time, we managed 
to maintain the structural and conformational integrity of the 
gelatin, to be further utilized for NP fabrication.
2.3. Fluorescence Enhancement
Enhancing the fluorescence will be crucial for various bio-
imaging purposes, especially in tissues. One strategy for 
improving the fluorescence intensity is the formation of alloy 
nanoclusters, by the doping of another noble metal during the 
nanoclusters growth. Silver and gold has been considered as a 
common combination for fabrication of alloy nanoclusters.[49,50] 
Modification of gold nanoclusters by silver has been reported 
to enhance the emission.[49,51] By using gelatin and GSH as 
ligands, it was important to optimize the Ag:Au molar ratio (0.4) 
to obtain the highest possible fluorescence intensity (Figure S8, 
Supporting Information). Surprisingly, doping Ag ions after 
6 h from the start of the reaction resulted in 2.5-fold increase 
in fluorescence rather than addition at the start of the reaction 
(Figure S8, Supporting Information). This might indicate the 
significance of the different noble metal atoms arrangement in 
the core for controlling the fluorescence properties of the alloy 
Adv. Healthcare Mater. 2019, 1900993
Figure 3. Investigating the effect of AuNC formation on the gelatin structure by comparing AuS and Aug to untreated gelatin. a) MALDI-TOF MS spectra 
recorded in positive mode show areas of similar mass (m/z). b) FT-IR spectra showed a negligible shift in amide I from 1629 cm−1 for gelatin to 1632 in 
both Aug and AuS, indicating β-sheets secondary structure (1623–1641 cm−1) for all of them. Aug is the optimized formulation of gelatin-stabilized nano-
clusters with reaction time of 3 h and pH 12. AuS: represents the optimized formulation using gelatin and glutathione with reaction time of 24 h and pH 11.
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nanoclusters. In another strategy, we investigated the addition 
of Ag ions after completion of the reaction of AuS formulation. 
Adjustments of the Ag:Au molar ratio, pH, and reaction time 
have been considered to maximize the fluorescence brightness 
(Figure S9, Supporting Information). Finally, two Ag-modi-
fied formulations; alloy AuNCs (AuAgS) and postsynthesis 
Ag-modified AuS (AuS+Ag) as in Table S1 (Supporting Infor-
mation) were selected for further characterization comparing 
to Aug and AuS. TEM images and measured size distributions 
are shown in Figures S7 and S10 (Supporting Information) of 
silver-modified and pure gold nanoclusters, respectively.
3D emission spectra of the four selected formulations are illus-
trated in Figure 4a. All samples showed broad emission spectra 
with assigned redshift due to the costabilization with GSH and 
enhancement of fluorescence upon modification using Ag. Both 
alloy nanoclusters formation and postsynthesis modification by Ag 
resulted in enhanced broad red emission bands upon excitation at 
380–550 nm. This offers a variety for the nanoclusters application 
for bioimaging over a wide range of fluorescence imaging settings. 
Absolute quantum yields (QYs) were measured using integrating 
sphere setup at different excitation wavelengths (400–550 nm) 
and were corrected for gelatin’s blue fluorescence (Figure S11a, 
Supporting Information). Modification with Ag resulted in about 
threefold enhancement in the QY upon excitation at 400 nm in 
comparison to AuS. The measurements revealed that Ag-mod-
ified AuNCs have an excitation-wavelength-dependent QY and 
this behavior is more pronounced in AuAgS. They show the max-
imum QY at 400 nm (24%) that declined to reach the value of 
AuS (≈9%) at 500–550 nm (Figure S11, Supporting Information). 
Nevertheless, modification by Ag resulted in lower decay rate of 
fluorescence when excited at 470 nm (Figure S11b, Supporting 
Information). Interestingly, it turns out that the enhancement of 
QY after the addition of Ag is correlated to a prolonged fluores-
cence lifetime (as summarized in Figure 4b).
2.4. Structure–Fluorescence Stability Relationship
Examination of the different AuNCs by XPS provided valuable 
knowledge about the oxidation state of the metal elements sup-
plying information about the core–shell composition of the 
nanoclusters. This opens the venue for better understanding 
of the nanoclusters formation and further correlation to their 
optical properties and photostability. Starting with Aug, Au 4f 
doublet can be deconvoluted into 3 distinct components with 
Au 4f7/2 at 84.3, 85.3, and 87.6 eV referring to Au (0), Au (I), 
and Au (III), respectively[52] (Figure 5a). So, after 3 h of reac-
tion with gelatin at 60 °C under alkaline conditions, Au (III) 
has been reduced partially to Au (I) and Au (0) to form AuNCs. 
However, Au (III)–protein complex has been assigned recently 
by Dixon and Egusa to also contribute to the fluorescence.[53] 
By virtue to the electron-donating groups in gelatin, Au (I) 
Adv. Healthcare Mater. 2019, 1900993
Figure 4. Optical properties of different AuNCs; Aug, AuS, AuAgS, and AuS+Ag. a) 3D emission spectra at excitation wavelength range 380–650 nm and 
the emission was recorded from 450 to 750 nm. b) Averaged lifetime (measured upon excitation at 470 nm) correlation to averaged absolute quantum 
yield% (measured upon excitation at 400–550 nm with 5 nm steps). The fluorescence around 450–550 nm is due to the gelatin autofluorescence.
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as an intermediate reduced state of gold has been produced, 
with a further reduction to Au (0). The aggregation of Au (0) 
results in the formation of a metal core with Au (I) on the sur-
face as the nanoclusters’ shell as a typical structure described 
in literature.[11,27,54] After 24 h of reaction, all Au (III) has been 
totally reduced to Au (I) and Au (0) (Figure 5a). On the other 
hand, coreduction with GSH resulted in complete reduc-
tion to Au (0), forming two populations of AuNCs of different 
core sizes with Au 4f7/2 peaks of Au (0) at 83.9 and 84.6 eV 
(Figure 5b). As previously reported, the higher binding energy 
of Au (0) indicates an increment in the core size.[27] Addition 
of Ag ions after the formation of AuS resulted in no change in 
the Au oxidation state with Au (0) peaks at 84.2 and 84.9 eV. 
Possibly, Ag ions are further reduced by the ligands and incor-
porated in or replaced some of the Au atoms at the surface of 
the nanoclusters. Other techniques as X-ray powder diffraction 
(XRD)[51] are required to confirm the atom arrangement within 
the clusters, however this was not possible with the current 
formulations due to the very minute amount of Ag and Au com-
pared to the gelatin matrix. Similarly, complete reduction of Au 
has been observed with the formation of alloy NCs (AuAgS), 
but interestingly with homogenous-sized population of AuNCs 
(Au 4f7/2 showed one peak at 84.5 eV) (Figure 5b). However, we 
cannot provide any evidence of Ag reduction especially with the 
difficulty to distinguish between Ag 3d5/2 corresponding to Ag 
(0) and Ag (I) without Auger line analysis, which was hindered 
by the very low concentration of Ag (Figure S12, Supporting 
Information) near the detection limit. Coreduction with GSH 
showed S 2p doublet with S 2p3/2 at 161.8 eV (SAu; SAg if 
present),[55] 163.8 eV (SH), 166.2 eV (oxidized sulfur: S (IV)) 
and 168.6 eV (oxidized sulfur: S (VI)[56] (Figure 5c) with very 
weak concentrations of 0.02, 0.03, 0.09, and 0.05 at% in AuAgS, 
respectively. A possible AuS bond may be formed; however 
data must be taken with caution due to the very low concentra-
tion of these elements, as the bulk of the sample constitutes 
out of gelatin, and the detection limit of the method. But on 
the other hand, the concentrations of Au and Ag were found in 
the same range with values of 0.02 and 0.01 at%, respectively, 
which supports the assumption of formed AuS and eventually 
AgS bonds.
AuNC structure together with the ligand plays the main role 
in controlling their optical properties due to electron transfer 
between the ligand and the metal surface and within the metal 
core. On the other hand, ligands as capping agents control 
the stability of the AuNC fluorescence in response to the dif-
ferent environmental conditions. Testing the robustness of 
AuNC fluorescence over a pH range (1.5–7) in comparison to 
the original synthesis environment, showed different degrees 
of stability arranged in the following order Aug < AuS < AuAgS 
< AuS+Ag (Figure 6a). However, all AuNCs showed consider-
able fluorescence stability at physiological pH; modifications 
with GSH and Ag have widened the pH stability range down 
to acidic conditions. Possessing the capability to manipulate 
the pH response of AuNCs provides the opportunity for various 
applications. For instance, the pH responsiveness showed by 
Aug could be utilized as a bioprobe to monitor pH changes in 
cancer cells.[57]
To investigate the contribution of gelatin and GSH in stabi-
lizing AuNCs, a trypsination experiment has been performed. 
Trypsin works specifically by hydrolyzing the peptide bonds on 
the carboxylic terminal of lysines and arginines. According to 
the trypsin concentration and the amino acid sequence of the 
protein, the maximum degree of hydrolysis varies.[58] In case 
of Aug, gelatin is the main reducing and capping agent for 
AuNCs. Gelatin fragmentation by trypsin resulted in drop of 
the fluorescence that was trypsin-concentration-dependent, as 
shown in Figure 6b. When the polypeptide loses its structure 
integrity that was responsible for holding the gold atoms and 
ions together, they dissociate and the fluorescence diminishes 
as observed at trypsin activity of 3.2 × 103 U mg−1 of gelatin. 
Interestingly, AuS fluorescence showed much higher stability 
to trypsin digestion. It can be envisaged that even after gelatin 
digestion, the AuNC structure is still preserved by binding to 
the thiolate groups of GSH and fractions of degraded gelatin. 
Adv. Healthcare Mater. 2019, 1900993
Figure 5. XPS spectra. a) Au 4f of AuNCs stabilized by gelatin at different reaction times (3 and 24 h). b) Au 4f of AuNCs stabilized by gelatin and 
glutathione (AuS, AuS+Ag, and AuAgS from lower to upper panel). Yellow curve: Au (0) at 84.1 ± 0.2 eV, purple curve: Au (0) at 84.7 ± 0.2 eV, orange: 
Au (I) at 85.5 ± 0.2 eV, green: Au (III). c) S 2p3/2 of different AuNCs (Aug, AuS, AuS+Ag, and AuAgS from lower to upper panel). Magenta-filled: 161.8 eV 
(SAu; SAg if present), black: 163.8 eV (SH), violet: 166.3 eV (oxidized sulfur: S (IV)), orange: 168.6 eV (oxidized sulfur: S (VI)).
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This provides valuable information about the role of both gel-
atin and GSH in AuNC protection. Whereas AuAgS showed 
intermediate stability to gelatin, AuS+Ag showed ultimate 
stability (Figure 6b). The latter even showed a slight increase in 
fluorescence, probably due to trypsin adsorption to the 
AuNCs.[59–61] This formulation will be interesting for long-term 
imaging of AuNCs in tissues due to their stability regardless 
of the integrity of gelatin as capping agent. On the other hand, 
AuAgS would be beneficial for mechanistic studies, especially 
when formulated as GNPs. Their bright fluorescence alongside 
with their intermediate sensitivity to polymer degradation will 
be a beneficial option to smartly track the NPs and follow their 
fate in tissues. In conclusion, NCs can offer stimuli-responsive 
fluorescence, i.e., are smart probes (different response to pH, 
enzymatic degradation, etc.), which can be manipulated by con-
trolling the NC and ligand compositions. This is an advantage 
of such imaging probes over standard dyes, where different 
stimuli responsiveness need careful selection of more than one 
dye to fulfill the same functions.
From the knowledge gained throughout the characteri-
zation of the different AuNCs’ optical properties and XPS 
studies introduced in this research work, accompanied with 
knowledge from literature about the general structure of gold 
nanoclusters,[11,13,54] simplified models for the nanoclusters 
have been proposed, as shown in Figure 6c. Aug, where nano-
clusters are produced only using gelatin, is considered the 
parent formulation that is further modified to other formula-
tions with different properties. These clusters showed a typical 
core–shell structure composed of Au (0) and Au (I) protected 
by gelatin as the only ligand. Further, addition of GSH resulted 
in complete reduction of Au (III) to Au (0) and nanoclusters 
formation of two different sizes. Additionally, GSH stabiliza-
tion provided higher protection of the nanocluster fluorescence 
toward pH change and enzymatic degradation. Addition of Ag 
ions after or during the synthesis of AuS resulted in enhance-
ment of the fluorescence intensity, QY, lifetime, and stability. 
Addition of Ag after the synthesis of AuS (AuS+Ag) led to no 
changes in the oxidation state of Au and some incorporation 
of Ag in the nanocluster surface. On the other hand, addition 
of Ag ions during the synthesis process of AuS seems to lead 
to the formation of smaller alloy nanoclusters (AuAgS) but of 
homogenous size.
Adv. Healthcare Mater. 2019, 1900993
Figure 6. Fluorescence stability of different AuNC against a) pH changes upon altering the pH from that of synthesis to lower pH values (1.5–7), 
b) gelatin digestion using different concentrations of trypsin at pH 7.4, 37 °C for 15 h. Fluorescence intensity was recorded at λmax for the different 
AuNCs (640 nm for Aug, 690 nm for AuS, and 700 nm for both AuS+Ag and AuAgS). This shows the effect of GSH and Ag ion addition on enhancing 
the AuNCs fluorescence stability against pH changes and trypsinization. c) Simplified proposed models for AuNC structure based on XPS data. Aug: 
showed a typical core–shell structure of Au (0) and Au (I), respectively. For all others, GSH-modified AuNCs, Au (0) was the only oxidation state with 
AuS bonding. The AuNCs have different core sizes (the biggest; AuS and the smallest AuAgS) referring to the Au (0) binding energy of 83.9 and 
84.5 eV, respectively.
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2.5. Formation of Protein Nanoparticles Using  
AuNC-Modified Gelatin
Such NPs were prepared by two-step desolvation method 
using AuNC-modified gelatin. Desolvation is the dehydra-
tion of gelatin by addition of an antisolvent, which results in 
coiling of the polypeptide chains. The first desolvation step 
was to separate the gelatin fractions of high molecular weight 
(HMW). Discarding the low molecular weight fractions of gel-
atin will enhance the homogeneity of the NP size and prevent 
irreversible aggregation.[62] The redissolved HMW gelatin was 
desolvated again to form NPs that were further cross-linked to 
preserve their conformation in aqueous environment. Different 
parameters have been optimized such as the antisolvent, the 
pH of gelatin solution, and the cross-linking agent.
NP formation is a complex phenomenon controlled by the 
polymer–antisolvent–solvent system. The diffusion and the 
affinity of the antisolvent to solvent and the polymer–solvent 
interactions influence the particle size.[63] Among different 
organic solvents (acetone, acetonitrile, isopropanol, ethanol), 
only methanol was suitable for AuNC-modified GNP forma-
tion. At the first desolvation step, pH of gelatin solution was 
adjusted to 7 to balance between preserving the fluorescence of 
AuAgS and reducing the charge of gelatin to induce precipita-
tion, while in the second desolvation, the pH was tuned to 8 to 
prevent NP aggregation. For cross-linking, glutaraldehyde, which 
is a common cross-linker for GNPs, resulted in complete loss of 
the Aug-modified GNP fluorescence, in agreement to a previous 
report by Khandelia et al.[64] This can be attributed to the cross-
linking mechanism of glutaraldehyde which is a non-zero length 
cross-linker that connects the alpha-amino groups of lysine 
residues.[65] Consequently, another cross-linker has been applied 
to preserve the fluorescence. This was a combination of N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
and N-hydroxysuccinimide (NHS); which is a zero-length cross-
linking agent that couples carboxylic to primary amine groups.[66]
Nanoparticles of narrow particle size distribution have been 
produced using Aug, AuS (Figure S13, Supporting Informa-
tion), and AuAgS-modified gelatin (Figure 7a). TEM showed the 
NPs nicely spherical in shape and non-aggregated and it, amaz-
ingly, revealed the internal distribution of the AuNCs. Among 
them, AuAgS–GNPs were of interest for further studies with 
Z-average size = 218.8 ± 1.7 nm and a size distribution displayed 
by the polydispersity index (PDI) of 0.073 ± 0.016. They showed 
high colloidal stability and further freeze drying with trehalose 
had no effect on the particle size following redispersion. The 
NP formation preserved the fluorescence emission spectrum 
of AuAgS (Figure 7b). Absolute QY was measured (λmax = 
400–550 nm) and corrected for the NP scattering using 
similar plain GNPs as a reference. They showed averaged 
QY = 14.8 ± 0.8% which was excitation-wavelength-independent, 
in contrast to the free nanoclusters. However, the formation of 
NPs have not changed the fluorescence lifetime behavior, as 
AuAgS–GNPs showed higher fluorescence lifetime in comparison 
to Aug and AuS–GNPs (Figure S15, Supporting Information).
The cytotoxicity of AuAgS–GNPs has been tested against 
human keratinocytes (HaCat cell line) using 3-(4,5-Dimethylth-
iazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which 
assesses the cell metabolic activity, after 24 h of incubation. The 
NPs showed no cytotoxicity (≈100% viability) at concentrations as 
high as 600 µg mL−1 (Figure 7c). This can be attributed to the bio-
compatibility of the materials used in the preparation including 
the nontoxic cross-linking agent (EDC). Concerns have been 
considered about the reported toxicity of silver ions. Neverthe-
less, the formulation was biocompatible, due to the very minute 
amount used, and the possible complete reduction of Ag ions 
during the nanoclusters preparation. Finally, the produced fluo-
rescent GNPs are safe biomaterials that pave the way for various 
biological applications including drug delivery.
2.6. Tissue Bioimaging Based on Linear Unmixing
Imaging and tracking of NPs in tissue using confocal laser 
scanning microscopy (CLSM) is a complex, even though ben-
eficial process, which provides deeper knowledge about nano-
pharmaceutical efficiency and fate. In this regard, we have 
selected human skin to test the ability of our developed AuAgS-
labeled GNPs to be imaged with tissue. Skin is known as a chal-
lenging tissue for imaging due to its density and autofluorescence 
that limit the process of suitable dye selection. Additionally, this 
imaging probe opens the avenue for better understanding of NP 
behavior in skin. This will be helpful for therapeutic purposes 
through transdermal drug delivery which gains a lot of attention 
recently to take over the invasive methods. On the other hand, 
occupational nanomaterial skin exposure can be hazardous for 
Adv. Healthcare Mater. 2019, 1900993
Figure 7. a) TEM image of AuAgS–GNPs with accelerating voltage 100 kV. b) Emission spectrum of the nanoparticles by excitation at 368 nm. 
c) Cytotoxicity testing of AuAgS–GNPs against human keratinocytes (HaCat cells) using different concentrations (25–800 µg mL−1) by MTT assay. 
Green-shaded box indicates the range where no toxicity is concluded.
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human health, especially over a long term. Overall, the developed 
fluorescent GNPs can be further applied to different biological 
applications that can even extend from skin to other tissues.
There are many endogenous autofluorescent substances in 
skin that may interfere with the analysis of different fluorophores. 
This renders the choice of a suitable fluorophore, with a distinct 
fluorescence from that of skin, not an easy option, especially due 
to the broad emission spectrum of skin. Even with suitable dyes, 
offsetting the skin’s fluorescence was the solution used by dif-
ferent research groups for imaging of NPs in skin.[67–70] However, 
the ability to image NPs together with skin structure will give 
visual evidence about the NP penetration within the tissue. In this 
regard, others resort to either dual-channel imaging followed by 
subsequent images overlapping,[71] or staining of skin prior to NP 
examination.[72] AuAgS–GNPs showed well-detected fluorescence 
in the red region of the spectrum (Figure 8a). This can be consid-
ered as the optimum properties of a fluorophore for imaging with 
skin. However, imaging of both NPs and skin simultaneously will 
be a more descriptive and time-saving method of analysis.
Linear unmixing is a technique that is used for separation of 
the signals of fluorophores of overlapping spectra. An algorithm 
is applied to analyze each pixel and segregate the mixed fluores-
cence signals arising from multiple fluorophores into individual 
components accrediting to spectral reference fingerprints.[73] 
AuAgS–GNPs showed a distinct fluorescence signal from 
that of skin (Figure 8a). Instead of canceling the skin fluores-
cence, linear unmixing has been utilized to separate NPs from 
skin signal. To test the accuracy of the method, NPs have been 
added to the skin surface and imaged directly. Figure 8b shows 
≈200 µm depth profiling (z-stack steps of 5 µm) of the NPs and 
skin, while 3D-constructed images are shown in Figure 8c. The 
images showed the NPs filling the furrows of the skin between 
the keratinocyte isles in a similar pattern to results shown ear-
lier by Stracke et al.[74] This indicates the applicability of the 
method for accurately separating the signals, so penetration 
studies within the tissue can be further analyzed.
Microneedles have been widely used as a minimally inva-
sive mechanical penetration method to deliver biotherapeutics 
through skin.[75] The nanocarriers labeled with NCs were loaded 
in dissolving microneedles composed of polyvinyl alcohol (PVA)/
sucrose. After microneedle insertion in skin, linear unmixing 
revealed the NP distribution within the skin tissue with a depth 
profile of 760 µm (Figure 8d). So, spectral imaging with linear 
unmixing offers a time-saving, noninvasive, and depth-revealing 
technique for simultaneous examination of the NPs and skin, 
which helps to avoid the artifacts produced during skin sec-
tioning and staining. Finally, the developed AuNC-modified 
GNPs showed to be an effective fluorescent probe for bioimaging 
with biological tissue such as skin. The developed nanoparticu-
late system with assistance of minimally invasive techniques as 
microneedle application, will be further investigated for deliv-
ering antigen through skin for transcutaneous vaccination with 
the ability of simultaneous bioimaging and particle tracking.
3. Conclusion
We proved the effectiveness of gelatin to produce fluorescent 
AuNCs, introducing different methods for tuning the emission 
wavelength alongside with the fluorescence intensity. Gold 
ions reduction-assisted by GSH, in one-pot synthesis, induced 
50 nm redshift in the nanoclusters emission alongside with 
stabilization against pH changes and enzymatic degradation. 
Modification by Ag ions either by doping during or post the 
nanoclusters formation resulted in enhancement of the QY and 
fluorescence lifetime. Finally as a result, four different AuNCs 
have been produced, showing variant stability in response to 
pH and enzymatic degradation, so they can be acclaimed for 
various biological applications. The optical properties–structure 
relationship has been established with the aid of XPS analysis. 
Model structures for the different formulated AuNCs have 
been constructed, summarizing the effect of different modifica-
tions. On the other hand, optimization of the synthesis process 
resulted in preserving the gelatin structure integrity, to be fur-
ther efficiently used for the preparation of GNPs. The NPs of 
size 218 nm showed distinct inner distribution of the AuNCs 
when examined by TEM. They preserved the fluorescence prop-
erties of the nanoclusters, thanks to the careful selection of the 
cross-linking agent (EDC/NHS). They showed biocompatibility 
toward human keratinocyte cell line up to 600 µg mL−1, which 
acclaims them for further applications in drug delivery. They 
have been imaged simultaneously with skin fluorescence using 
noninvasive time-saving method by combining CLSM and 
linear unmixing, achieving a depth profile of 760 µm. Finally, 
our study can be considered as a platform for putting insights 
into the design, optimization, and better understanding of 
the AuNC formation and properties. The development of 
AuNC-modified GNPs represents a very promising approach 
for imaging in a challenging tissue as skin that can extend to 
various theranostic and pharmaceutical applications, preferably 
antigen delivery for transcutaneous vaccination.
4. Experimental Section
Materials: Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4 . 3H2O), 
gelatin type B (from bovine skin, gel strength ≈75 g Bloom), silver nitrate, 
EDC, NHS, D-(+)-trehalose dihydrate, PVA (Mowiol 4-88, Mw ≈31 000), 
sucrose, methanol, dimethyl sulfoxide (DMSO) were all purchased from 
Sigma-Aldrich, Steinheim Germany. Ninhydrin (2,2-dihydroxyindane-1,3-
dione) was purchased from Merck, Darmstadt, Germany. Trypsin from 
bovine pancreas (activity: 3273.4 U mg−1) was obtained from PanReac 
Applichem, Darmstadt, Germany. All chemicals were utilized without 
further purification. Milli-Q ultrapure water was used for all experiments.
Synthesis of Gelatin-Stabilized AuNCs: Gold nanoclusters stabilized by 
gelatin were prepared by adding HAuCl4 to gelatin solution followed by 
adjusting the pH using 1 n sodium hydroxide. The reaction was carried 
out for 24 h under vigorous mixing in a thermomixer (MHR, Hettich 
Benelux, Geldermalsen, The Netherlands) at 60 °C. Different HAuCl4 
concentrations (1 × 10−3–20 × 10−3 m) and different pH values (7–12) 
were tested for AuNC formation evaluated by fluorescence evolution. The 
optimized nanoclusters (Aug) were utilized for further investigations.
Synthesis of Gelatin-Stabilized AuNCs Modified by Glutathione: 
In one-pot reaction, GSH with different concentrations 
(5 × 10−3–25 × 10−3 m) was added to 4% w/v gelatin, followed by addition 
of 10 × 10−3 m HAuCl4. All other settings were adjusted as shown before 
and the reaction proceeded for 24 h. The optimized formulation (AuS) 
was applied for further modifications as will be shown later.
Gelatin Structure Integrity: Selected formulations showing the 
highest fluorescence were repeated following the previously mentioned 
procedure while varying the reaction times (1–24 h). The fluorescence 
at the maximum wavelength was plotted against time and further 
Adv. Healthcare Mater. 2019, 1900993
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Figure 8. a) Emission spectra of skin and AuAgS–GNPs recorded by confocal microscopy at λex 405 nm. b,c) 3D confocal imaging of NPs applied 
to the skin surface. (b) z-stacks starting from skin surface to 210 µm depth in tissue with 5 µm steps. This shows the NPs (red) filling the furrows 
between the keratinocyte isles (green). The fluorescence channels were separated from the crude fluorescence using linear unmixing algorithm with 
reference to the fluorescence spectra of skin and NPs. (c) 3D images constructed from the z-stacks showing upper, bottom, and side view (from left 
to right) of the scanned area. d) 3D confocal imaging of NP-loaded microneedles applied into skin, constructed from z-stacks recorded over 760 µm 
depth with 10 µm steps, showing the NPs (red) penetration depth (Zx and Zy) into skin tissue (green). The XY-plane shows a horizontal cut at 300 µm 
depth displaying the nanoparticle distribution.
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the samples were examined for gel formation after cooling to 4 °C. 
The free amine groups in gelatin were quantified by ninhydrin test over 
different time intervals of interaction with gold. Briefly, pH of AuNC-
modified gelatin was adjusted to 7 by 1 n HCl and mixed vigorously 
(1000 rpm) with 3% ninhydrin solution in 90% DMSO at 80 °C for 
5 min. Then, the mixture was cooled down to room temperature for 
30 min and absorbance was measured at 575 nm. Calibration curve 
was constructed using glycine as a standard[76] following the same 
procedure. FT-IR and MALDI-TOF MS were performed. Freeze-dried 
samples of selected AuNC-modified gelatin were scanned for their FT-IR 
spectrum between 4000 and 400 cm−1 (Spectrum 400, FT-IR/FT-NIR 
Spectrometer, PerkinElmer, Rodgau, Germany). For MALDI-TOF MS, 
samples were analyzed in positive mode with a matrix of sinapinic acid 
using Applied Biosystems 4800 MALDI TOF/TOF analyzer (Applied 
Biosystems, Warrington, Cheshire, UK).
Synthesis of Ag-Modified AuNCs Stabilized by Gelatin and Glutathione: 
The GSH-modified gelatin-stabilized AuNCs synthesized after optimized 
conditions (AuS) were further modified using silver ions following two 
different protocols. I) To form alloy metal NCs, AgNO3 was added 
during the formation of the nanoclusters. Effect of different Ag/Au 
ratios, reaction times and pH was tested. II) To modify the surface of 
AuNCs, AgNO3 was added after the synthesis of AuNCs. For screening, 
fluorescence spectra were recorded for all tested formulations 
(550–850 nm) upon excitation at 368 nm using Microplate reader 
(Infinite M200, Tecan Group Ltd., Männedorf, Switzerland).
Characterization of Selected AuNC Formulations: 3D-fluorescence 
spectra, time-correlated single photon counting, alongside with the 
fluorescence quantum yield measurement were performed. Further 
details for the setup can be found in the Supporting Information. 
Fluorescence imaging was carried out by confocal microscope (LSM 710, 
Zeiss, Jena, Germany) using excitation laser of 405 nm and emission 
was detected between 600 and 740 nm. TEM was performed using a 
JEOL Model JEM 2010 microscope (JEOL GmbH, Freising, Germany). 
Robustness of AuNC fluorescence against changes in environmental 
conditions (pH and enzymatic activity) was tested. The emission at the 
maximum wavelength was recorded upon excitation at 368 nm for the 
as prepared AuNCs and after pH change. On the other hand, AuNCs 
in PBS (pH 7.4, 5 mg mL−1) were mixed with different concentrations 
of trypsin solutions at 500 rpm and 37 °C for 15 h. Fluorescence was 
recorded before and after reaction with trypsin.
XPS Analysis: Samples’ pH was adjusted to 7, freeze-dried, and 
then analyzed using a KAlpha+ spectrometer (ThermoFisher Scientific, 
East Grinstead, UK) equipped with a microfocused, monochromated 
Al Kα X-ray source (400 µm spot size). The charge compensation 
system was applied using electrons of 8 eV energy and low-energy 
argon ions to prevent any localized charge buildup. The electrons’ 
kinetic energy was measured by a 180° hemispherical energy analyzer 
in the constant analyzer energy mode at 50 eV pass energy. Data 
acquisition and processing using the Thermo Avantage software was 
described elsewhere.[77] The Scofield sensitivity factors were applied for 
quantification.[78] All spectra were referenced to the C 1s peak at 285.0 eV 
binding energy (CC, CH).
Preparation of AuNC-Modified GNPs: They were fabricated using two-
step desolvation method and cross-linking. For the first precipitation, 
methanol was added to the AuNC-modified gelatin and shaken 
to precipitate the high molecular weight fractions and the turbid 
supernatant was discarded. The gel-like mass of gelatin was freeze-
dried, weighed, and dissolved in water at 50 °C, giving rise to 2% w/v 
solution. The pH of gelatin solution was adjusted to 8 using 1 n NaOH 
and methanol was added dropwise while stirring until the first turbidity 
was observed, indicating the formation of NPs. They were further 
cross-linked using a mixture of EDC/NHS that was added dropwise. 
The NP dispersion was kept under stirring at 600 rpm for 18 h. They 
were purified by centrifugation (Thermo Fisher Scientific, Osterode am 
Harz, Germany) at 20 000 × g for 1 h at 20 °C followed by washing that 
was repeated 3 times. Following, the NP dispersion was freeze-dried 
using 3% w/v trehalose as a cryoprotectant to be further used for other 
experiments.
Cell Culture: Human keratinocytes cell line (HaCaT) was cultured in 
Dulbecco’s modified Eagle’s medium (Gibco, Thermo Fischer Scientific, 
Paisley, UK) supplemented with 10% v/v fetal calf serum and 100 U mL−1 
penicillin–streptomycin. The cells were incubated at 37 °C under 
5% CO2. Cytotoxicity of the selected Ag–Au alloy NC (AuAgS)-modified 
GNPs was tested using MTT assay for cell viability. Further details can 
be found in the Supporting Information.
Bioimaging of GNPs with Skin Tissue: Excised human skin was obtained 
from abdominal plastic surgeries after the approval of the Research Ethic 
Committee of Saarland, Germany (Ärztekammer des Saarlandes, Dec. 2008) 
and permission of the volunteers. Further details about skin preparation and 
the examination setup can be found in the Supporting Information. First, 
untreated human skin samples and AuAgS-modified GNPs were separately 
scanned for their emission spectrum in the range 600–740 nm by confocal 
microscopy using lambda mode upon excitation at 405 nm. The treated 
skin samples were tested applying the same parameters. Two groups of 
skin samples were treated with AuAgS-modified GNPs; a) by addition of 
NPs to skin surface and b) by insertion of AuAgS-modified GNP-loaded 
microneedles into skin. Using the linear unmixing algorithm available in 
the Zen Black software, the fluorescence signals of the NPs were separated 
from that of skin. For depth profiling, objectives (LCI Plan-Neofluar 25×/0.8 
Imm Korr DIC M27 and  EC Plan-Neofluar 10×/0.3 M27) have been used 
and z-stacks were recorded with 5 and 10 µm steps for the surface and 
microneedle applications, respectively, and 3D images were constructed.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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